![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Zhejiang Changming Pharmaceutical Co., Ltd. Tiantai Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Ramipril, Process 2, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2012-379 - Rev 01
This Chemical Type CEP, issued on October 14, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1368 associated with this CEP further emphasizes